User:StephanVCornell/Antimicrobial resistance

Bacteria
The five main mechanisms by which bacteria exhibit resistance to antibiotics are:


 * 1) Drug inactivation or modification: for example, enzymatic deactivation of penicillin G in some penicillin-resistant bacteria through the production of β-lactamases. Drugs may also be chemically modified through the addition of functional groups by transferase enzymes; for example, acetylation, phosphorylation, or adenylation are common resistance mechanisms to aminoglycosides. Acetylation is the most widely used mechanism and can affect a number of drug classes.
 * 2) Alteration of target- or binding site: for example, alteration of PBP—the binding target site of penicillins—in MRSA and other penicillin-resistant bacteria. Another protective mechanism found among bacterial species is ribosomal protection proteins. These proteins protect the bacterial cell from antibiotics that target the cell's ribosomes to inhibit protein synthesis. The mechanism involves the binding of the ribosomal protection proteins to the ribosomes of the bacterial cell, which in turn changes its conformational shape. This allows the ribosomes to continue synthesizing proteins essential to the cell while preventing antibiotics from binding to the ribosome to inhibit protein synthesis.
 * 3) Alteration of metabolic pathway: for example, some sulfonamide-resistant bacteria do not require para-aminobenzoic acid (PABA), an important precursor for the synthesis of folic acid and nucleic acids in bacteria inhibited by sulfonamides, instead, like mammalian cells, they turn to using preformed folic acid.
 * 4) Reduced drug accumulation: by decreasing drug permeability or increasing active efflux (pumping out) of the drugs across the cell surface These pumps within the cellular membrane of certain bacterial species are used to pump antibiotics out of the cell before they are able to do any damage. They are often activated by a specific substrate associated with an antibiotic, as in fluoroquinolone resistance.
 * 5) Ribosome splitting and recycling: for example, drug-mediated stalling of the ribosome by lincomycin and erythromycin unstalled by a heat shock protein found in Listeria monocytogenes, which is a homologue of HflX from other bacteria. Liberation of the ribosome from the drug allows further translation and consequent resistance to the drug.

Recent Developments:

 * Cross-resistance: Exposure to one antibiotic can confer resistance to others, a critical factor in managing treatment regimens.
 * Microgravity impacts on resistance: Studies have shown that non-pathogenic strains of E. coli can develop antibiotic resistance under simulated microgravity conditions, suggesting that the physical environment plays a role in resistance dynamics.
 * Carbapenemases: The spread of carbapenemase-producing organisms, like those producing New Delhi metallo-beta-lactamase 1 (NDM-1), continues to be a significant challenge. These enzymes confer resistance to a broad spectrum of beta-lactam antibiotics and are primarily found in gram-negative bacteria such as E. coli and Klebsiella pneumoniae.

'Impact of Resistance: The pathogens causing the most deaths associated with resistance include Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Streptococcus pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa''. In 2019, these organisms were linked to approximately 929,000 deaths due to resistance and contributed to 3.57 million deaths associated with infections.'''